Skip to main content
ACRUX LIMITED logo

ACRUX LIMITED — Investor Relations & Filings

Ticker · ACR ISIN · AU000000ACR3 LEI · 529900XV9111G3SMCP21 ASX Manufacturing
Open in API
Filings indexed 1,156 across all filing types
Latest filing 2026-06-15 Proxy Solicitation & In…
Country AU Australia
Listing ASX ACR

About ACRUX LIMITED

https://www.acrux.com.au

Acrux Limited focuses on the development and commercialization of topical and transdermal drug delivery products. The company utilizes proprietary technology platforms to create a pipeline of generic and specialty pharmaceutical products, including creams, gels, ointments, and metered-dose sprays. It specializes in the formulation of complex topical medicines, leveraging expertise in skin penetration and drug delivery systems to improve patient compliance and therapeutic outcomes. The business model involves the internal development of products through to regulatory submission and subsequent commercialization via strategic partnerships. The company maintains a diverse portfolio targeting various therapeutic areas, with a significant emphasis on meeting regulatory requirements for international markets.

Recent filings

Filing Released Lang Actions
Notice of Extraordinary General Meeting/Proxy Form 30 pages 810.5KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Notice of Extraordinary General Meeting (EGM) and contains a detailed explanatory memorandum. It outlines resolutions to be voted on at the EGM, including approval of share issues, options, employee share ownership plan, and securities acquisition approvals by executives and directors. The content focuses on soliciting votes for these corporate actions and providing shareholders with necessary information for the meeting. It does not contain financial statements, earnings information, audit content, legal proceedings, or results of voting but is instead the meeting notice and explanatory material. This fits the definition of Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings such as AGMs or EGMs. The document is also lengthy and detailed, confirming it is more than a mere announcement. Therefore, the classification is PSI with a high confidence score.
2026-06-15 English
Appendix 3Y Oldham 2 pages 237.7KB
Director's Dealing Classification · 95% confidence The document is an ASX Appendix 3Y “Change of Director’s Interest Notice” under listing rule 3.19A.2, detailing a director’s personal securities transactions (shares, options, rights). This matches the definition of a Director’s Dealing (insider trades) report.
2026-06-02 English
Appendix 3Y Dobinson 2 pages 196.6KB
Director's Dealing Classification · 95% confidence The document is an Appendix 3Y ‘Change of Director’s Interest Notice’ filed under ASX Listing Rule 3.19A.2, detailing a director’s acquisition of securities (exercise of unlisted rights and share holdings) and updating their relevant interests. This is a report of insider share transactions by a company director, fitting the Director’s Dealing category.
2026-06-02 English
Appendix 3Y Brumley 2 pages 236.3KB
Director's Dealing Classification · 95% confidence The document is Appendix 3Y “Change of Director's Interest Notice” filed under ASX Listing Rule 3.19A.2 disclosing a director’s holdings, acquisitions, and disposals of securities. This is a report of personal share transactions by a company director, fitting the “Director’s Dealing” category.
2026-06-02 English
Application for quotation of securities - ACR 7 pages 19.6KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX Appendix 2A form titled ‘Application for quotation of securities,’ detailing the issuance and quotation of new shares under an employee incentive scheme, including the number of securities and listing details. This is a direct announcement of a share issue/capital change rather than a full report or regulatory attestation, matching the Share Issue/Capital Change category.
2026-06-02 English
Application for quotation of securities - ACR 5 pages 16.7KB
Share Issue/Capital Change Classification · 92% confidence The document is an ASX Listing Rules Appendix 2A “Application for quotation of securities” detailing the conversion of employee incentive scheme performance rights into fully paid ordinary shares and the subsequent quotation of those shares. This is a direct announcement of a share issue/capital change. Therefore, it falls under the Share Issue/Capital Change category (SHA).
2026-06-02 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.